From owner-chemistry@ccl.net Sun Aug 11 20:55:00 2013 From: "Oellien, F (Frank) frank.oellien++msd.de" To: CCL Subject: CCL: GCC2013 - Extended Deadline for Oral Contributions & Short Notes Message-Id: <-49071-130811173209-17759-EmlQljclorNDOsyaeQrt3A:_:server.ccl.net> X-Original-From: "Oellien, F (Frank)" Content-Language: en-US Content-Transfer-Encoding: 8bit Content-Type: text/plain; charset="iso-8859-1" Date: Sun, 11 Aug 2013 23:32:01 +0200 MIME-Version: 1.0 Sent to CCL by: "Oellien, F (Frank)" [frank.oellien#msd.de] Dear Colleagues, The deadline for the submission of oral contributions for the 9. German Conference on Chemoinformatics (November 10 - 12, Fulda, Germany) has been extended to August 15, 2013. Please submit your talk via the conference webpage http://www.gdch.de/gcc2013 You can also submit posters until September 1, 2013. We have also started a new session format at the GCC2013 which should offer an additional opportunity for PhD - the Research Telegrams. Supervisors should recommend suitable candidates to Dr. Oliver Koch (see webpage for details). Independently of the research telegrams, PhD students can also submit their work as oral presentation or poster. Please consider to apply for scholarships. There are also a few exhibition slots left. Please contact me directly, if you are interested in an exhibition booth. Best regards Frank Oellien Dr. Frank Oellien Senior Scientist, Bioinformatics AH - Molecular Discovery Sciences MSD Animal Health Innovation GmbH Zur Propstei 55270 Schwabenheim, Germany E-Mail:      frank.oellien-.-msd.de Phone:     +49 (6130) 948 365                             Fax:         +49 (6130) 948 517                              Home       http://www.msd-animal-health.com Hinweis: Diese Email wird von einem Unternehmen der deutschen MSD-Gruppe versandt. Hierzu gehören folgende Vertriebsunternehmen: Humanarzneimittel: MSD Sharp & Dohme GmbH, Lindenplatz 1, 85540 Haar; HR München B 6194 Geschäftsführer: Hanspeter Quodt (Vors.), Dr. Claus Dollinger, Dr. Veit Stoll Aufsichtsratsvorsitzender: Dr. Axel Breitstadt Tierarzneimittel: Intervet Deutschland GmbH, Feldstr. 1a, 85716 Unterschleißheim; HR München B 138151 Geschäftsführer: Dr. Daniel Sicher (Vors.), Christoph Kölsch Weitere Unternehmen der deutschen MSD-Gruppe siehe http://info.msd.de/pflichtangaben